0H68 Stock Overview
Through its subsidiaries, provides supplemental health and life insurance products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Aflac Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$111.12 |
| 52 Week High | US$116.85 |
| 52 Week Low | US$75.41 |
| Beta | 0.96 |
| 11 Month Change | -2.82% |
| 3 Month Change | 5.63% |
| 1 Year Change | 36.01% |
| 33 Year Change | 100.12% |
| 5 Year Change | 106.27% |
| Change since IPO | 22.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0H68 | GB Insurance | GB Market | |
|---|---|---|---|
| 7D | 2.6% | 0.5% | -0.4% |
| 1Y | 36.0% | -7.8% | 5.6% |
Return vs Industry: 0H68 exceeded the UK Insurance industry which returned -7.6% over the past year.
Return vs Market: 0H68 exceeded the UK Market which returned 5.5% over the past year.
Price Volatility
| 0H68 volatility | |
|---|---|
| 0H68 Average Weekly Movement | 2.4% |
| Insurance Industry Average Movement | 3.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0H68 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0H68's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1955 | 12,785 | Dan Amos | www.aflac.com |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Aflac Incorporated Fundamentals Summary
| 0H68 fundamental statistics | |
|---|---|
| Market cap | US$61.84b |
| Earnings (TTM) | US$3.81b |
| Revenue (TTM) | US$17.30b |
16.2x
P/E Ratio3.6x
P/S RatioIs 0H68 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0H68 income statement (TTM) | |
|---|---|
| Revenue | US$17.30b |
| Cost of Revenue | US$9.48b |
| Gross Profit | US$7.82b |
| Other Expenses | US$4.01b |
| Earnings | US$3.81b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.86 |
| Gross Margin | 45.20% |
| Net Profit Margin | 22.01% |
| Debt/Equity Ratio | 49.7% |
How did 0H68 perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield29%
Payout RatioDoes 0H68 pay a reliable dividends?
See 0H68 dividend history and benchmarks| Aflac dividend dates | |
|---|---|
| Ex Dividend Date | Nov 20 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 14 days |
Does 0H68 pay a reliable dividends?
See 0H68 dividend history and benchmarks